Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of CytomX Therapeutics Inc (NASDAQ: CTMX) closed at $2.75 in the last session, down -8.03% from day before closing price of $2.99. In other words, the price has decreased by -$8.03 from its previous closing price. On the day, 1.96 million shares were traded.
Ratios:
We take a closer look at CTMX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.11.
Piper Sandler Upgraded its Neutral to Overweight on May 28, 2024, whereas the target price for the stock was revised from $2.25 to $3.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when McCarthy Sean A. sold 37,656 shares for $0.60 per share. The transaction valued at 22,556 led to the insider holds 995,195 shares of the business.
Ogden Christopher sold 8,551 shares of CTMX for $5,122 on Mar 18 ’25. The Chief Financial Officer now owns 201,026 shares after completing the transaction at $0.60 per share. On Mar 18 ’25, another insider, Chu Yu-Waye, who serves as the Chief Medical Officer of the company, sold 4,025 shares for $0.60 each. As a result, the insider received 2,411 and left with 135,725 shares of the company.
Valuation Measures:
As of this moment, CytomX’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.94 while its Price-to-Book (P/B) ratio in mrq is 8.85.
Stock Price History:
Over the past 52 weeks, CTMX has reached a high of $3.00, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 80.62%, while the 200-Day Moving Average is calculated to be 148.27%.
Shares Statistics:
A total of 157.54M shares are outstanding, with a floating share count of 104.28M. Insiders hold about 33.81% of the company’s shares, while institutions hold 35.39% stake in the company.
